Hot Investor Mandate: Growth Capital Firm with New Fund Invests in Biotech, Medtech, and Research Tools with Capacity to Invest At Least $20M

20 Jun

A life sciences-focused growth capital firm recently raised almost $1B for their new fund, which will invest broadly in the healthcare space. The firm seeks to make venture and growth stage investments ranging from $20M-$70M in the form of equity. The fund prefers to lead or co-lead most deals and may or may not seek a board seat along with an investment. The firm has a diverse team of pharmaceutical and finance professionals and seeks to add value to portfolio companies through strategic guidance and a steady flow of capital, allowing companies to focus on developing their products and executing their business plan.

The firm focuses on the following healthcare verticals: biotech/biopharma, medical devices, and life science / research tools and diagnostics. The fund is agnostic to therapeutic area and therapeutic modality, but does favor companies developing and commercializing solutions for significant unmet and under-met medical needs. As for biopharma drug companies, the fund typically likes to see at least GLP toxicology data for pre-clinical assets but ideally early safety/tolerability and biological activity/biomarker data in humans.

The firm has no strict company or management team requirements, but favors experienced/proven management teams and entrepreneurs who are highly skilled and knowledgeable in the specific area (technology and indication area) they are pursuing.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: